Cliditer, S.A. DE C.V.

Mexico City, Mexico City 6700

0 studies enrolling now · 5 studies all time

What they study most

Arthritis, Psoriatic, Arthritis, Rheumatoid, Psoriatic Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis — Completed
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) — Completed
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors — Completed